Europe Autoimmune Diagnostics Market Share, Size, Forecast and Trends by 2021

07/ago/2017 12:09:00 Market Data Forecast Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The Europe Autoimmune Diagnostics Market was worth $3.39 billion in 2016 and estimated to reach $ 4.08 billion by the end of 2021 with a growing potential of 3.78%.


Autoimmune diseases arise once the immune system attacks one or more of the body's normal parts as if they were invaders. When the immune system fails to identify "self" it may produce immune cells or antibodies that target its own tissues, cells and organs. Developed countries of Europe have projected high occurrence rate of auto immune disorders compared to other regions of the auto immune disease diagnostics. The strike rate of auto immune diseases is more in women compared to men. The presence of large untapped opportunities available in the developing eastern European countries is expected to fuel the growth of the market.


Full report at:


High occurrence of auto immune disorders, Supportive government policies, increasing public awareness, increased government funding aimed at improving healthcare infrastructure, introduction of advanced technologies such as novel biomarkers and portable diagnostic equipment are the major factors driving the growth of the market. The key restraints that inhibiting the growth of the auto immune diagnostics market are low prevalence of localized auto immune disorders as compared to systemic diseases and growing rate of diagnostics errors.


The Europe Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.


Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Ankylosing Spondylitis.


Based on End users into Hospitals, Research centres, and diagnostic laboratories and on the basis of geography, the Europe Auto Immune Diagnostics market is analysed under various regions namely U.K, Germany, Italy, France and Spain.


Request sample:


Some of the key players operating in Europe include Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.


About Market Data Forecast:


The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit,



Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206


Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

blog comments powered by Disqus è un servizio offerto da Factotum Srl